The crucial linkage required between regenerative medicine bioprocessors and clinicians

Regenerative Medicine

Volumn 3, Issue 4, 2008, Pages 435-442

  Mason, Chris ^a   Dunnill, Peter ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AVULSION INJURY; BIOPROCESS; BRACHIAL PLEXUS AVULSION INJURY; CARTILAGE CELL; CELL THERAPY; CELL TRANSPLANTATION; CHEMICAL BURN; EDITORIAL; EMBRYONIC STEM CELL; GOOD CLINICAL PRACTICE; HUMAN; KNEE INJURY; NONHUMAN; OLFACTORY ENSHEATHING CELL; OSTEOARTHRITIS; PARKINSON DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; REGENERATIVE MEDICINE; RETINA MACULA AGE RELATED DEGENERATION; SAFETY; SPINAL CORD INJURY; LABORATORY PERSONNEL; ORGANIZATION AND MANAGEMENT; PHYSICIAN; STANDARD;

CELL TRANSPLANTATION; HUMANS; LABORATORY PERSONNEL; PHYSICIANS; PRACTICE GUIDELINES AS TOPIC; REGENERATIVE MEDICINE;

EID: 49149110488     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460751.3.4.435     Document Type: Editorial

References (38)

1. Blundel J: Observations on the transfusion of blood. The Lancet 12, 321-324 (1829).
2. + hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity. Transfusion 46, 1934-1942 (2006).
3. Wood FM: Clinical Potential of autologous epithelial suspension. Wounds 15, 16-22 (2003).
4. Raisman G: Specialized neuroglial arrangement may explain the capacity of vomeronasal axons to reinnervate central neurons. Neuroscience 14, 237-254 (1985).
5. Li Y, Decherchi P, Raisman G: Transplantation of olfactory ensheathing cells in spinal cord lesions restores breathing and climbing. J. Neurosci. 23, 727 (2003).
6. Htut M, Misra P, Anand P, Birch R: Pain phenomena and sensory recovery following brachial plexus avulsion injury and surgical repairs. J. Hand Surg. (British Volume) 31, 596-605 (2006).
7. Htut M, Misra VP, Anand P, Birch R, Carlstedt T: Motor recovery and the breathing arm after brachial plexus surgical repairs, including re-implantation of avulsed spinal roots into the spinal cord. J. Hand Surg. (European Volume) 32, 170-178 (2007).
8. Feron F, Perry C, Cochrane J et al.: Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain 128, 2951-2960 (2005).
9. Mayhew TA, Williams GR, Senica MA, Kuniholm G, du Moulin GC: Validation of a quality assurance program for autologous cultured chondrocyte implantation, Tissue Eng. 4, 325 (1998).
10. Browne JE, Sasser TM, Branch TP: Autologous chondrocyte implantation. Tech. Knee Surgery 5, 238-251 (2006).
11. Klimanskaya I, Hipp J, Rezal KA, West M, Atala A, Lanza R: Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells 6, 217-245 (2004).
12. Vugler A, Lawrence J, Walsh J et al.: Embryonic stem cells and retinal repair. Mech. Dev. 124, 807-829 (2007).
13. da Cruz L, Chen FK, Ahmado A, Greenwood J, Coffey P: RPE transplantation and its role in retinal disease. Prog. Retinal Eye Res. 26, 598-635 (2007).
14. Thumann G, Aisenbrey S, Schaefer F, Bartz-Schmidt KU: Instrumentation and technique for delivery of tissue explants to the subretinal space. Opthalmologica 220, 170-173 (2006).
15. Zhu N, Warner RM, Simpson C et al.: Treatment of burns and chronic wounds using a new cell transfer dressing for delivery of autologous keratinocytes. Eur. J. Past. Surg. 28, 319-330 (2005).
16. De Luca M, Pellegrini G, Green H: Regeneration of squamous epithelia from stem cells of cultured grafts. Regen. Med. 1, 45-57 (2006).
17. Bjorklund A: Cell Therapy for Parkinson's disease: problems and prospects. Stem Cells: Nuclear Reprogrammiqg and Therapeutic Applications. Novartis Foundation Symposium 265, 174-187 (2005).
18. Dunnett SB, Bjorklund A, Lindvall O: Cell therapy in Parkinson's disease - stop or go? Nat. Rev. 2, 365-369 (2001).
19. Zamorano L, Li Q, Jain S, Kaur G: Robotics in neurosurgery: state of the art and future technological challenges. Int. J. Robotics Compt. Assist. Surg. 1, 7-22 (2004).
20. Willers C, Partsalis T, Zheng M-H: Articular cartilage repair: procedures versus products. Expert Rev. Med. Devices 4, 373-392 (2007).
21. De Bie C: Genzyme: 15 years of cell and gene therapy research. Regen. Med. 2, 95-97 (2007).
22. Kondziolka D, Steinberg GK, Wechsler L et al.: Neurotransplantation for patients with subcortical motor stroke: a Phase II randomized trial. J. Neurosurg. 103, 38-45 (2005).
23. Bakay RA. Neural transplantation. J. Neurosurg. 103, 6-8 (2005).
24. Hernon CA, Dawson RA, Freedlander E et al.: Clinical experience using cultured epithelial autografts leads to an alternative methodology for transferring skin cells from the laboratory to the patient. Regen. Med. 1, 809-821 (2006).
25. Mason C, Hoare M: bioprocessing: building a conceptual framework based on early studies. Tissue Eng. 13, 301-311 (2007).
26. Zoro BJH, Owen S, Drake RAL, Hoare M: The impact of process stress on suspended anchorage-dependant mammalian cells as an indicator of likely challenges for regenerative medicines. Biotechnol. Bioeng. 99, 468-474 (2007).
27. Webb IJ, Coral FS, Andersen JW et al.: Sources and sequelae of bacterial contamination of haematopoietic stem cell components: implications for safety of hematotherapy and graft engineering. Transfusion. 36, 782-788 (1996).
28. Schwella N, Rick O, Heuft HG et al.: Bacterial contamination of autologus bone marrow reinfusion of culture-positive grafts does not result in clinical sequalae during the post transplantation course. Vox Sang. 74, 88 (1998).
29. Phinney DG, Kopen G, Righter W, Webster S, Tremain N, Prackop DJ: Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J. Cell Biochem. 75, 424-436 (1999).
30. Clarke SA, Hoskins NL, Jordan GR, Marsh DR: Healing of an ulnar defect using a proprietary TCP bone graft substitute, JAX, in association with autologous osteogenic cells and growth factors. Bone 40, 939-947 (2007).
31. Salaway T, Ilic D: Logistics of stem cell isolation, preparation and delivery for heart repair: concerns of clinicians, manufacturers, investors and public health. Regen. Med. 3, 83-91 (2008).
32. Shapiro AM, Ricordi C, Hering BJ et al.: International trial of the Edmonton protocol for islet transplantation. N. Engl. J. Med. 355, 1318-1330 (2006).
33. Camarillo DB, Krummel TM, Salisbury JK: Robotic technology in surgery: past, present, and future. Am. J. Surg. 188, S2-S15 (2004).
34. Ott HC, Brechkten J, Swingen C et al.: Robotic minimally invasive cell transplantation for heart failure. J. Thorac. Cardiovasc. Surg. 132, 170-173 (2006).
35. Lepore AC, Bakshi A, Swanger SA, Rao MS, Fischer I: Neural precursor cells can be delivered into the injured cervical spinal cord by intrathecal injection at the lumbar cord. Brain Res. 1045, 206-216 (2005).
36. Menasche P: Skeletal myoblasts as a therapeutic agent. Prog. Cardiovasc. Dis. 50, 7-17 (2007).
37. Mason C, Dunnill P: The strong financial case for regenerative medicine. Regen. Med. 3, 351-363 (2008).
38. Wallis LA, Greaves I: Injuries associated with airbag deployment. Emerg. Med. J. 19, 490-493 (2002).